Related Experiment Videos
Nonsynonymous TNNI3K mutations and phenotypes: More than a "simple" cardiomyopathy
Sven Dittmann1, Eric Schulze-Bahr1
1Institute for Genetics of Heart Diseases (IfGH), University Hospital Münster, Münster, Germany.
Heart Rhythm
|August 1, 2018
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Polygenic risk modulates myocardial repolarization and T-wave geometry in congenital long-QT syndrome type 1: evidence from digital ECG phenotyping.
Frontiers in cardiovascular medicine·2026
Clinical Profile and Mode of Initiation of Spontaneous Ventricular Tachyarrhythmias in Patients With Brugada Syndrome (START-BrS).
JACC. Clinical electrophysiology·2026
A MATLAB Algorithm to Automatically Estimate the QT Interval and Other ECG Parameters and Validation Using a Machine Learning Approach in Congenital Long-QT Syndrome.
Journal of cardiovascular translational research·2025
Current management of transition and multidisciplinary care of patients with inherited and rare cardiomyopathies in Europe: results of the European Reference Network for rare and low prevalence complex diseases of the heart.
European heart journal. Quality of care & clinical outcomes·2025
Long QT syndrome in children and adolescents: risk factors and outcomes in a large German cohort.
European heart journal·2025
Cardiac arrhythmias and genetics - current stage.
Medizinische Genetik : Mitteilungsblatt des Berufsverbandes Medizinische Genetik e.V·2025
Regenerative medicine for neurodegenerative diseases:History, Strategies, and Clinical Advances.
Translational research : the journal of laboratory and clinical medicine·2026
Emerging molecular mechanism of neuroinflammation in Parkinson's disease: A JAK/STAT and TGFβ/SMAD signaling crosstalk.
Biochimica et biophysica acta. General subjects·2026
Safety and adverse event profiles in neuromodulation therapies for drug-resistant epilepsy.
Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026